Insider Buying: Creo Medical Group PLC (LON:CREO) Insider Acquires 1,179,000 Shares of Stock

Creo Medical Group PLC (LON:CREO) insider Kevin Crofton bought 1,179,000 shares of the firm’s stock in a transaction that occurred on Friday, December 13th. The shares were purchased at an average price of GBX 17 ($0.22) per share, for a total transaction of £200,430 ($254,805.49).

Kevin Crofton also recently made the following trade(s):

• On Monday, October 21st, Kevin Crofton purchased 2,916,666 shares of Creo Medical Group stock. The stock was acquired at an average price of GBX 24 ($0.31) per share, with a total value of £699,999.84 ($889,905.72).

Creo Medical Group Price Performance

CREO stock opened at GBX 17.25 ($0.22) on Wednesday. The stock has a market capitalization of £62.41 million, a price-to-earnings ratio of -287.50 and a beta of 0.86. The company has a quick ratio of 2.19, a current ratio of 3.24 and a debt-to-equity ratio of 29.96. Creo Medical Group PLC has a 52-week low of GBX 12 ($0.15) and a 52-week high of GBX 50 ($0.64). The stock’s fifty day simple moving average is GBX 18.12 and its 200-day simple moving average is GBX 26.23.

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.